Telo Genomics Corp.
TDSGF
$0.04
$0.0119.66%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.21% | 39.63% | 68.53% | -52.12% | -40.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.92% | 10.30% | 28.98% | -26.01% | -19.20% |
| Operating Income | 2.92% | -10.30% | -28.98% | 26.01% | 19.20% |
| Income Before Tax | 2.96% | -16.65% | -31.01% | 28.52% | 19.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.96% | -16.65% | -31.01% | 28.52% | 19.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.96% | -16.65% | -31.01% | 28.52% | 19.17% |
| EBIT | 2.92% | -10.30% | -28.98% | 26.01% | 19.20% |
| EBITDA | 2.47% | -11.45% | -30.63% | 25.44% | 18.73% |
| EPS Basic | 27.78% | 16.39% | 6.35% | 33.72% | 22.86% |
| Normalized Basic EPS | 29.41% | 18.42% | 7.50% | 33.33% | 22.73% |
| EPS Diluted | 0.00% | 16.39% | -11.11% | 17.44% | 2.67% |
| Normalized Diluted EPS | 29.41% | 18.42% | 7.50% | 33.33% | 22.73% |
| Average Basic Shares Outstanding | 34.64% | 39.62% | 40.26% | 7.66% | 4.56% |
| Average Diluted Shares Outstanding | 34.64% | 39.62% | 40.26% | 7.66% | 4.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |